PTP
DFTX

Platform Technology Partners’s Definium Therapeutics DFTX Stock Holding History

Platform Technology Partners’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-750
Closed -$16K – 228
2021
Q4 		$16K Sell
750
-250
-25% -$7.98K 0.01% 223
2021
Q3 		$35K Hold
1,000
– – 0.02% 228
2021
Q2 		$52K Buy
+1,000
New +$52.5K 0.02% 252

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCI
Data Collective IV Palo Alto, California $78.6M AUM 55.41% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $4.12B AUM 32.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Platform Technology Partners's DFTX Position: Q1 2022 in Review

Platform Technology Partners sold out of Definium Therapeutics (DFTX) in Q1 2022, closing a stake of 750 shares — an estimated $16K sold.

Platform Technology Partners first reported a position in DFTX in Q2 2021 and held it in 3 quarters. The position peaked at $52K in Q2 2021. 159 funds tracked by Wall St. Rank hold DFTX as of Q1 2022.

  • Platform Technology Partners reported no remaining Definium Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Platform Technology Partners sold 750 Definium Therapeutics shares in Q1 2022, an estimated $16K.
  • Platform Technology Partners first reported a position in Definium Therapeutics in Q2 2021 and held it in 3 quarters.
  • Platform Technology Partners's Definium Therapeutics position peaked at $52K in Q2 2021.
  • 159 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2022.

Based on Platform Technology Partners's 13F filing for Q1 2022, filed 3 May 2022.